Finance

Lists
DHER34:BVMF
Danaher Corporation Bdr
39,36 BRL
0,00%
(0,00) 1D
9-окт., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DHER34...
Open
39,18 BRL
High
39,36 BRL
Low
39,18 BRL
Mkt. cap
154,52 млд
Avg. vol.
2,36 миң
Volume
404,00
52-wk high
45,87 BRL
52-wk low
27,94 BRL
Shares outstanding
702,99 млн
No. of employees
59 миң
Open
39,18 BRL
High
39,36 BRL
Low
39,18 BRL
Mkt. cap
154,52 млд
Avg. vol.
2,36 миң
Volume
404,00
52-wk high
45,87 BRL
52-wk low
27,94 BRL
Shares outstanding
702,99 млн
No. of employees
59 миң
News stories
From web sources and news partners
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr
CEORainer M. Blair
Employees59 миң
Founded1969
Headquarters-
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
6,05 млд
6,84 млд
5,95 млд
6,26 млд
Cost of goods sold
2,53 млд
2,86 млд
2,36 млд
2,61 млд
Cost of revenue
2,53 млд
2,86 млд
2,36 млд
2,61 млд
Research and development expenses
378,00 млн
438,00 млн
387,00 млн
412,00 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 млд
2,03 млд
1,84 млд
2,01 млд
Operating expense
2,27 млд
2,46 млд
2,23 млд
2,42 млд
Total operating expenses
4,80 млд
5,32 млд
4,59 млд
5,03 млд
Operating income
1,26 млд
1,52 млд
1,36 млд
1,24 млд
Other non operating income
-
-87,00 млн
-
-
EBT including unusual items
1,08 млд
1,37 млд
1,24 млд
1,08 млд
EBT excluding unusual items
1,19 млд
1,39 млд
1,33 млд
1,19 млд
Income tax expense
168,00 млн
190,00 млн
206,00 млн
208,00 млн
Effective tax rate
15,61%
13,84%
16,68%
19,29%
Other operating expenses
-
-
-
-
Net income
908,00 млн
1,20 млд
1,03 млд
870,00 млн
Net profit margin
15,00%
17,51%
17,29%
13,89%
Earnings per share
1,89
2,23
2,06
1,94
Interest and investment income
3,00 млн
13,00 млн
27,00 млн
61,00 млн
Interest expense
-67,00 млн
-55,00 млн
-63,00 млн
-107,00 млн
Net interest expenses
-64,00 млн
-42,00 млн
-36,00 млн
-46,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,88 млд
2,14 млд
1,99 млд
1,90 млд
Gain or loss from assets sale
-9,00 млн
9,00 млн
-
-
AI content may include mistakes. Learn more
Google колдонмолору